small-logo
ProfessionalsCapabilitiesInsights & NewsCareersLocations
About UsAlumniOpportunity & InclusionPro BonoCorporate Social Responsibility
Stay Connected:
facebookinstagramlinkedintwitteryoutube
Site Search
  • Professionals (89)
  • Capabilities (39)
  • Experience (101)
  • Insights & News (2,797)
  • Other Results (41)

Professionals 89 results

Emilie Woodhead
Emilie Woodhead
Of Counsel
  • Los Angeles
Email
+1 213-615-1823
vCard

Of Counsel

  • Los Angeles
Joan Fife
Joan Fife
Partner
  • San Francisco
Email
+1 415-591-1513
vCard

Partner

  • San Francisco
Delilah Efimov
Delilah Efimov
Associate
  • Chicago
Email
+1 312-558-3244
vCard

Associate

  • Chicago
View All Professionals

Capabilities 39 results

Practice Area

Corporate Governance

Our attorneys have extensive experience counseling U.S. and multinational public companies across a range of industries in all aspects of corporate governance, securities, and compliance matters. We advise public companies, boards of directors and their committees, and senior executives on the corporate governance and compliance matters that public companies and their leadership confront—from board structuring and succession planning to shareholder activism and SEC regulation. Drawing on our experience as seasoned counselors, we keep clients abreast of evolving trends and best practices to proactively manage any governance or compliance issues. We have assembled one of the most experienced teams of any law firm in the country that’s counseling public companies....Read more

Practice Area

Labor & Employment

Our Labor & Employment Practice is one of the largest and most experienced practices among the country’s multi-disciplined law firms. Our attorneys represent global employers of all types and sizes—ranging from the Fortune 100 to privately held startups—often serving as national, regional, or preferred counsel to many of these major employers....Read more

Practice Area

ERISA Litigation

As a firm of choice for many major businesses, we represent employers, fiduciaries, boards of directors, benefit plans, and plan administrators in all aspects of ERISA litigation, including claims relating to fiduciary liability, plan investments, excessive fees, plan qualification, plan termination, reversion of excess assets, retiree medical benefits, severance and employment contract matters, tax liability matters, and retirement and welfare benefit claims....Read more

Experience 101 results

Experience

|

April 6, 2026

MLBPI’s Licensing Fight Ends in Victory and Settlement with DraftKings

Winston is representing MLB Players Inc. (MLBPI), which serves as the exclusive group licensing representative for all MLB (major league baseball) players. MLBPI sued several online sportsbook and mobile-betting platforms, including DraftKings, over their use of hundreds of MLB player images and likenesses without MLBPI’s consent....Read more

Experience

|

April 2, 2026

Business Combination and Secured Financing of Keo World and Maha Capital AB

Served as legal counsel to KEO World, Inc., a Miami-based fintech platform specializing in embedded credit and B2B digital payments, in connection with its business combination with Maha Capital AB, a publicly listed investment company on Nasdaq Stockholm. The transaction, which closed on April 2, 2026, was structured as a reverse triangular merger through which KEO World became a wholly owned subsidiary of Maha, with KEO World's parent entity receiving approximately 141 million newly issued Maha shares and nearly 49.2 million earn-out warrants as consideration. In connection with the closing, Maha also executed two directed capital raises totaling USD 27 million at SEK 16 per share and announced a planned third raise of USD 8 million ahead of a contemplated dual listing on a U.S. national securities exchange. Based on publicly available disclosures, the combined transaction has been valued at approximately USD 680 million....Read more

Experience

|

March 30, 2026

Winston advised NextStage AM on its investment in Evoluderm, a leading French player in the hygiene and beauty sector.

Winston & Strawn LLP Paris advised NextStage AM on its investment in Evoluderm, a leading French player in the hygiene and beauty sector. This growth capital transaction, led by NextStage AM as a minority investor, will provide Nathalie and Gabriel Aiach – founders and majority shareholders with over 20 years’ expertise in the cosmetics sector – with the means to accelerate their ambition: to make Evoluderm an iconic brand, ranking among the world leaders in accessible, high-quality beauty. Founded in 2004, Evoluderm has established itself over the last five years as a benchmark in the health and beauty sector, distributed in over 100 countries. The brand has thus experienced remarkable growth, with turnover tripling over the last three years to reach nearly €40 million in 2025. With the support of NextStage AM, Evoluderm is embarking on an ambitious development plan to consolidate its position as a market leader. ...Read more
View All Experience

Insights & News 2,797 results

Capital Markets & Securities Law Watch

|

April 27, 2026

|

4 Min Read

SEC Grants Exemptive Relief for Shortened Equity Tender Offers

On April 16, 2026, the Securities and Exchange Commission’s (the SEC) Office of Mergers and Acquisitions in the Division of Corporation Finance (the Division) issued an exemptive order (the Order) permitting certain tender offers for equity securities to remain open for a minimum of 10 business days rather than the standard 20 business days, subject to strict conditions designed to preserve investor protections.

In the Media

|

April 16, 2026

|

4 Min Read

Winston Secures Transformative Antitrust Verdict for States in Live Nation and Ticketmaster Trial

A Winston & Strawn team, led by Jeffrey Kessler, secured an antitrust verdict on behalf of more than 30 states and the District of Columbia, with a Manhattan federal jury finding Live Nation Entertainment and Ticketmaster liable for violating federal and state antitrust laws in a decision that has the potential to transform the concert, music, and ticketing industry. The jury concluded that Ticketmaster unlawfully maintained a monopoly in the primary ticketing market for major concert venues and that Live Nation unlawfully monopolized the large amphitheater market, compelling artists to use its promotion services to access its venues. Jurors further found that this conduct resulted in higher ticket fees, leading to an approximate $1.72 overcharge per ticket for consumers....Read more

In the Media

|

April 15, 2026

|

2 Min Read

Anne Murray and Guy Singer Join Winston in White Collar & Government Investigations Practice

Winston & Strawn recently announced that Anne Murray and Guy Singer joined the firm’s Washington, D.C. and New York offices respectively as partners in the Litigation Department. The two bring invaluable white collar defense, corporate investigations, and compliance experience to the firm’s White Collar & Government Investigations Practice. Both are seasoned white-collar defense and compliance attorneys, who represent companies and individuals in matters involving fraud, bribery, corruption, and ethics issues....Read more
View All Insights & News

Other Results 41 results

Site Content

What Is an IPO Quiet Period?

A quiet period, also known as as the ‘pre-filing period,’ is the period that begins on the date an offering commences (often the date that Company retains an investment bank) and ends upon the public filing of the registration statement. It is referred to as the quiet period because of the SEC’s restrictions on publicity about the company and/or promoting its offering....Read more

Site Content

What Is the Cooling-Off Period for an IPO?

The cooling-off period is the period of time between the public filing of a registration statement with the SEC and the date the registration statement becomes effective. During this period, no sales may take place. Written offers may only be made with a prospectus meeting the requirements of Section 10 of the Securities Act. Certain oral offers including roadshow presentations may occur during this time along with testing the waters (TTW) activities with certain potential investors.  ...Read more

Law Glossary

What Exclusivity Periods Are Associated with Biosimilars?

An applicant may not submit an aBLA until four years after the reference product is licensed by the FDA. (See BPCIA § 351(k).) Further, any biosimilar licenses “may not be made effective” until 12 years after the reference product was licensed. (See BPCIA § 351(l).)...Read more
Logo
facebookinstagramlinkedintwitteryoutube

Copyright © 2026. Winston & Strawn LLP

AlumniCorporate Transparency Act Task ForceDEI Compliance Task ForceEqual Rights AmendmentLaw GlossaryThe Oval UpdateWinston MinutePrivacy PolicyCookie PolicyFraud & Scam AlertsNoticesSubscribeAttorney Advertising